Sun Pharmaceutical Industries informs about press release

14 Jun 2024 Evaluate

Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial of MM-II in Patients with Painful Knee Osteoarthritis (OA), which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1718.45 -1.15 (-0.07%)
31-Dec-2025 14:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.45
Dr. Reddys Lab 1270.00
Cipla 1506.30
Zydus Lifesciences 913.50
Lupin 2110.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×